Moderna’s biovalent booster candidates meet primary endpoint of superiority against Omicron variants in trai
Moderna said Monday that both of its bivalent Omicron-targeting booster candidates (mRNA-1273.214 and mRNA-1273.222) trigger a superior antibody response compared…